An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet In Healthy Subjects.
Latest Information Update: 22 Feb 2021
At a glance
- Drugs Atorvastatin (Primary)
- Indications Alzheimer's disease; Atrial fibrillation; Cardiovascular disorders; Diabetic foot ulcer; Heart failure
- Focus Pharmacokinetics
- Sponsors Pfizer; Viatris
- 18 Jun 2009 New trial record